Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic …

12/24/2014 majac Your Health Matters

24, 2014 /PRNewswire/ — Novo Nordisk today announced that the Food and … diet and increased physical activity for chronic weight management in … that a sustained weight loss of 5% to 10% provides significant health benefits for …
Go to Source

Share on Facebook

Save